IMU 1.02% 4.9¢ imugene limited

Media Thread, page-144

  1. 2,136 Posts.
    lightbulb Created with Sketch. 2363
    Watching this interview, you get the serious impression that Imugene will soon be announcing a licensing deal with a Big Pharmaceutical company to bring the HER-Vaxx vaccine to market.

    We're looking at an upfront payment (likely $100 million+) and ongoing royalties on Billions in revenue to be generated from this vaccine over the next two decades.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.